Skip to main content

Table 2 Results of overall and subgroup analyses for C1772T and G1790A polymorphisms

From: Correlation between hypoxia-inducible factor-1α C1772T/G1790A polymorphisms and head and neck cancer risk: a meta-analysis

 

No.

T versus C

TT versus CC

TC versus CC

TT + TC versus CC

TT versus TC + CC

OR

95% CI

P(Z)

OR

(95% CI)

P(z)

OR

(95% CI)

P(z)

OR

(95% CI)

P(z)

OR

(95% CI)

P(z)

C1772T

                

 Overall

7

1.66

0.92–2.99

0.095

2.27

1.17–4.42

0.016

0.98

0.70–1.38

0.914

1.16

0.85–1.59

0.355

11.53

1.11–120.4

0.041

 PCR-RFLP

4

2.44

0.90–6.64

0.081

2.27

1.17–4.42

0.016

0.86

0.55–1.34

0.506

1.14

0.78–1.67

0.503

11.53

1.11–120.4

0.041

 Sequencing

3

1.20

0.70–2.03

0.506

1.20

0.69–2.09

0.514

1.20

0.69–2.09

0.514

 Caucasian

2

1.26

0.84–1.90

0.270

2.16

1.09–4.27

0.028

0.69

0.40–1.17

0.168

1.02

0.66–1.57

0.926

2.28

1.15–5.51

0.018

 Asian

4

1.37

0.88–2.13

0.159

1.30

0.82–2.07

0.269

1.34

0.85–2.12

0.213

 HB

3

1.31

0.90–1.90

0.162

0.92

0.57–1.48

0.736

1.13

0.73–1.74

0.582

 PB

4

2.87

0.82–10.0

0.099

2.01

0.75–5.41

0.168

1.05

0.64–1.73

0.843

1.20

0.76–1.89

0.442

22.82

0.28–1887.8

0.165

 OC

5

1.95

0.70–5.43

0.201

2.01

0.75–5.41

0.168

0.89

0.57–1.40

0.612

1.01

0.66–1.54

0.957

22.82

0.28–1887.8

0.165

G1790A

No.

A versus G

AA versus GG

AG versus GG

AA + AG versus GG

AA versus AG + GG

OR

95% CI

P(Z)

OR

(95% CI)

P(z)

OR

(95% CI)

P(z)

OR

(95% CI)

P(z)

OR

(95% CI)

P(z)

 Overall

6

4.11

0.84–20.15

0.081

72.11

2.08–2502.4

0.018

1.94

0.83–4.55

0.128

3.57

0.97–13.14

0.055

58.05

1.70–1985.8

0.024

 PCR-RFLP

4

8.39

0.98–72.1

0.053

72.11

2.08–2502.4

0.018

2.81

0.91–8.72

0.074

7.00

1.18–41.68

0.032

58.05

1.70–1985.8

0.024

 Sequencing

2

1.01

0.50–2.03

0.975

1.01

0.50–2.06

0.975

1.01

0.50–2.06

0.975

 Caucasian

2

2.18

0.16–30.19

0.562

2.10

0.16–28.19

0.577

2.24

0.15–34.32

0.563

 Asian

3

1.59

0.67–3.78

0.294

1.57

0.69–3.58

0.283

1.59

0.67–3.76

0.290

 HB

2

0.86

0.43–1.72

0.667

   

0.85

0.42–1.73

0.660

0.85

0.42–1.73

0.660

 PB

4

9.43

1.20–73.9

0.033

72.11

2.08–2502.4

0.018

3.22

1.28–8.08

0.013

7.83

1.48–41.37

0.015

58.05

1.70–1985.8

0.024

 OC

4

9.66

1.31–71.15

0.026

72.11

2.08–2502.4

0.018

3.17

1.26–7.92

0.014

7.92

1.58–39.64

0.012

58.05

1.70–1985.8

0.024

  1. OC, oral cancer; HB, hospital-based study; PB, population-based study; PCR-RFLP, polymerase chain reaction–restriction fragment length polymorphism